SenesTech names Jack Karabees as EVP of sales
Get Alerts SNES Hot Sheet
Join SI Premium – FREE
SenesTech, Inc. (NASDAQ: SNES) has appointed Jack Karabees as Executive Vice President of Sales, according to a company press release dated June 29, 2026.
Karabees brings more than three decades of B2B sales leadership experience to the role. He will oversee SenesTech's sales organization and be responsible for revenue growth, market expansion, and customer relationships across key channels.
Most recently, Karabees served as Chief Revenue Officer of Intercept Telehealth. Before that, he held the roles of President and Executive Vice President of Sales at Consult A Doctor, where he helped guide the company through its acquisition by Teladoc Health (NYSE: TDOC).
Earlier in his career, Karabees served as Executive Vice President of Corporate Finance, Sales and Marketing at Entic, a cloud-based analytics platform, which was later acquired by Blackstone Group and subsequently sold to Aquicore. He also served as Senior Vice President of Sales at eLabor, a workforce management software company whose divisions were separately acquired by Microsoft Corporation and ADP.
Karabees had previously been working with SenesTech in a consulting capacity before his formal appointment.
"Jack has built and led successful professional B2B sales organizations throughout his career and has extensive experience helping companies define the processes and systems necessary to achieve significant scale," said Michael Edell, President and Chief Executive Officer of SenesTech.
SenesTech markets rodent fertility control products under its Evolve and ContraPest brands, serving both consumer and professional pest management markets.
You May Also Be Interested In
- Chipotle adds Albert Baldocchi to Audit and Risk Committee
- Nocera files to register 7.5 million shares under SEC Form S-3
- Byrna Technologies to acquire HERO Defense Systems assets for $1.25M
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share